enVVeno director plans $123 Rule 144 share sale

Director Francis G. Duhay filed a Rule 144 notice to potentially sell 11 NVNO common shares valued at $123 in total.

Rhea-AI Filing Summary

enVVeno Medical Corp (NVNO) received a Form 144 notice from director Francis G. Duhay covering a proposed sale of restricted common stock under Rule 144. The notice states an intention to sell 11 shares of common stock through broker The Charles Schwab Corporation on NASDAQ.

The filing reports an aggregate market value of $123.00 for the planned sale and indicates that these 11 shares were acquired in an open market purchase on December 31, 2024.

Key Figures

Shares proposed to be sold: 11 shares Aggregate market value of proposed sale: $123.00 Shares outstanding: 682,722 shares +1 more

4 metrics

Shares proposed to be sold 11 shares Common stock covered by the Rule 144 notice

Aggregate market value of proposed sale $123.00 Value of 11 NVNO common shares listed in Form 144

Shares outstanding 682,722 shares Common shares outstanding for this class as reported in the form

Shares acquired 11 shares Common shares acquired on December 31, 2024 via open market purchase

Key Terms

Rule 144, aggregate market value, open market purchase

3 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

aggregate market value financial

"COMMON | THE CHARLES SCHWAB CORPORATION ... | 11 | 123.00 | 682722"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

open market purchase financial

"COMMON | 12/31/2024 | OPEN MARKET PURCHASE | OPEN MARKET"

An open market purchase is when a company buys its own shares on public stock exchanges the same way any investor would, rather than through a private deal. Investors care because these purchases reduce the number of shares available, can boost earnings per share and share price, signal that management thinks the stock is undervalued, and use company cash that might otherwise go to reinvestment or dividends — like a business quietly buying back its own tickets at the box office.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filed for NVNO disclose?

It discloses that director Francis G. Duhay has filed a notice of proposed sale under Rule 144 for 11 shares of enVVeno Medical Corp common stock, to be sold through The Charles Schwab Corporation on NASDAQ.

How many NVNO shares are covered by this Rule 144 notice?

The notice covers a proposed sale of 11 shares of enVVeno Medical Corp common stock. This is the amount listed in both the securities information and securities-to-be-sold sections.

What is the aggregate market value of the NVNO shares in this Form 144?

The Form 144 lists an aggregate market value of $123.00 for the 11 shares of enVVeno Medical Corp common stock that are proposed to be sold under Rule 144.

When and how were the NVNO shares proposed for sale acquired?

The 11 NVNO common shares were acquired on December 31, 2024 through an open market purchase, as stated in the securities-to-be-sold section of the Form 144.

How many enVVeno Medical Corp shares are reported outstanding in this filing?

The Form 144 reports 682,722 shares of enVVeno Medical Corp common stock as outstanding, in the column that lists the number of shares outstanding for the class of securities.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/11/2026 - 10:20 AM Accepted by SEC EDGAR 09/11/2026 - 10:20 AM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001760582
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	enVVeno Medical Corp
SEC File Number	001-38325
Address of Issuer	70 DOPPLER IRVINE CALIFORNIA 92618
Phone	949-261-2900
Name of Person for Whose Account the Securities are To Be Sold	Duhay Francis
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
COMMON	THE CHARLES SCHWAB CORPORATION 3000 Schwab Way Westlake TX 76262	11	123.00	682722	09/11/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
COMMON	12/31/2024	OPEN MARKET PURCHASE	OPEN MARKET			11	12/31/2024	NA

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	09/11/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	06/12/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	FRANCIS G DUHAY
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)